Eli Lilly and Company is a
prestigious company university
established in 1876 in United States. It is represented
by 238 scientists in the AD Scientific Index. The
university’s scientists are particularly concentrated in
Natural Sciences (62 scientists), Medical and Health Sciences (54 scientists), and Engineering & Technology (13 scientists).
* Total H Index Rankings
Ranking Based
On Selection: 26
Insulin receptor
diabetes
systems biology
NCAM
FGFR
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
12
0.444
* Total H Index Rankings
Ranking Based
On Selection: 27
Clinical trial design
missing data
generalized linear models
surrogate marker
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
14
0.538
* Total H Index Rankings
Ranking Based
On Selection: 28
Drug Discovery & Development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
13
0.500
* Total H Index Rankings
Ranking Based
On Selection: 29
Design of Clinical Trials
Statistics
Data Analysis
Modeling
Methods for Observational Studies
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
21
0.840
* Total H Index Rankings
Ranking Based
On Selection: 30
Multivariate Latent Variable Methods
Optimization
Process Modeling
Advanced Control
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
17
0.680
* Total H Index Rankings
Ranking Based
On Selection: 31
Synchrotron Beamlines
Macromolecular Crystallography
Drug Discovery and Design
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
14
0.560
* Total H Index Rankings
Ranking Based
On Selection: 32
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
20
0.833
* Total H Index Rankings
Ranking Based
On Selection: 33
Muscle & Metabolism
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
13
0.542
* Total H Index Rankings
Ranking Based
On Selection: 34
crystallization
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
14
0.636
* Total H Index Rankings
Ranking Based
On Selection: 35
External Innovation and Drug Discovery
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
21
9
0.429
* Total H Index Rankings
Ranking Based
On Selection: 36
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
12
0.600
* Total H Index Rankings
Ranking Based
On Selection: 37
diabetes
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
12
0.600
* Total H Index Rankings
Ranking Based
On Selection: 38
immunity
informatics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
10
0.500
* Total H Index Rankings
Ranking Based
On Selection: 39
Real World Evidence
Health Policy
Methodology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
19
11
0.579
* Total H Index Rankings
Ranking Based
On Selection: 40
Diabetes
Obesity
Metabolic Diseases
Cardiovascular and Diabetic Complications
NASH
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
19
8
0.421
* Total H Index Rankings
Ranking Based
On Selection: 41
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
18
10
0.556
* Total H Index Rankings
Ranking Based
On Selection: 42
Type 2 diabetes
non-alcoholic fatty liver disease
exercise training
metabolic flexibility
mitochondrial function
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
16
1.000
* Total H Index Rankings
Ranking Based
On Selection: 43
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
14
0.875
* Total H Index Rankings
Ranking Based
On Selection: 44
PK/PD
Drug Discovery
antibodies
proteins
insulin
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
11
0.688
* Total H Index Rankings
Ranking Based
On Selection: 45
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
11
0.688
* Total H Index Rankings
Ranking Based
On Selection: 46
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
9
0.563
* Total H Index Rankings
Ranking Based
On Selection: 47
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
14
0.933
* Total H Index Rankings
Ranking Based
On Selection: 48
Diabetic Side Complications
Signal Transduction
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
14
0.933
* Total H Index Rankings
Ranking Based
On Selection: 49
Hepatocellular Carcinoma
Urothelial Carcinoma
Clinical Trial Design
Clinical Research
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
13
0.867
* Total H Index Rankings
Ranking Based
On Selection: 50
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
12
0.800
Vladislav Kiselyov
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
12
0.444
Yongming Qu
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
14
0.538
Clinical trial design
missing data
generalized linear models
surrogate marker
Chafiq Hamdouchi
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
13
0.500
Mallikarjuna Rettiganti
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
21
0.840
Design of Clinical Trials
Statistics
Data Analysis
Modeling
Methods for Observational Studies
Salvador Garcia Munoz
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
17
0.680
Multivariate Latent Variable Methods
Optimization
Process Modeling
Advanced Control
Jordi Benach
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
14
0.560
Synchrotron Beamlines
Macromolecular Crystallography
Drug Discovery and Design
Celia N Cruz
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
20
0.833
Yvonne Monique Kobayashi
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
13
0.542
Jeremy Merritt
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
22
14
0.636
Tim Luker
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
21
9
0.429
Paul H Berg
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
12
0.600
Leonard C Glass
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
12
0.600
Ernst R Dow
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
10
0.500
James F Murray
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
19
11
0.579
Eugene W Shek
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
19
8
0.421
Diabetes
Obesity
Metabolic Diseases
Cardiovascular and Diabetic Complications
NASH
Tomoko Ishizuka|Tomoko Morimoto-Ishizuka, Tomoko Morimoto
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
18
10
0.556
Bram Brouwers
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
16
1.000
Type 2 diabetes
non-alcoholic fatty liver disease
exercise training
metabolic flexibility
mitochondrial function
Xintian You
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
14
0.875
Ryan J Hansen
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
11
0.688
Guilherme Rocha
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
11
0.688
Cen Gao
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
9
0.563
Caitlin D Lowery
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
14
0.933
Jessica Overstreet
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
14
0.933
Ryan Widau
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
13
0.867
Hepatocellular Carcinoma
Urothelial Carcinoma
Clinical Trial Design
Clinical Research
Jonathan T Sims
Eli Lilly and Company
Indianapolis, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
12
0.800